Clinical Trials on Methicillin Resistant Staphylococcus Aureus (MRSA) in Switzerland

Total 6 results

University Hospital, Basel, Switzerland

Recruiting

Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection (TARGET III)

Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)

Switzerland
University Hospital, Basel, Switzerland
propatient foundation Basel

Completed

Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus (TARGET II)

Staphylococcus Aureus Infection

Switzerland
University Hospital, Basel, Switzerland

Completed

Staphylococcus Aureus Caught in Action at the Site of Infection (PROSA)

Staphylococcus (S.) Aureus Infection

Switzerland
MedImmune LLC
National Institute of Allergy and Infectious Diseases (NIAID); Innovative Medicines... and other collaborators

Completed

Study of the Efficacy and Safety of MEDI4893 (SAATELLITE)

Staphylococcus Aureus Pneumonia

Spain, Belgium, United States, France, Germany, Czechia, Greece, Switzerland, Hungary, Portugal
Lindenhofgruppe AG

Completed

Preoperative Decolonization and Surgical Site Infections in Orthopaedic Surgery - 2 Year Outcome in Prosthetic Surgery (DECO-SSI)

Staphylococcus Aureus | Surgical Site Infection | Orthopaedic Surgery | Prevention

Switzerland
AO Clinical Investigation and Publishing Documentation

Completed

Clinical Priority Program-Bone Infection Registry (CPPInfection)

Staphylococcus Aureus | Bone Infection

United States, Belgium, Denmark, China, Argentina, Germany, Japan, Switzerland, Austria, Canada

Clinical Trials on Methicillin Resistant Staphylococcus Aureus (MRSA) in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations